Hydrophobically Modified Polypeptoids for Stable Liposome Drug Loading

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing liposome delivery systems struggle with incorporating poorly water-soluble compounds, as they destabilize the lipid bilayer and have limited capacity, making it difficult to deliver hydrophobic drugs effectively.

Innovation Solution

Hydrophobically modified polypeptoids are introduced, which can interact with lipids and form multilamellar structures on liposome surfaces, allowing for the delivery of hydrophobic drugs by disrupting or stabilizing lipid bilayers.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If hydrophobic compounds are incorporated into the lipid bilayer of liposomes, then the delivery of hydrophobic drugs is enabled, but the liposome structure becomes destabilized and the incorporation capacity is limited

Engineering Contradiction:
Improveincorporation capacity of hydrophobic compoundsVSAvoidlipid bilayer stability
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The patent introduces polypeptoid molecules as intermediary carriers that possess both hydrophobic regions (for binding hydrophobic drugs) and hydrophilic regions (for interacting with the aqueous environment and liposome surface). These polypeptoid-drug conjugates act as mediators that deliver hydrophobic compounds to liposomes without directly compromising lipid bilayer integrity, thus resolving the contradiction between incorporation capacity and structural stability.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention creates a composite delivery system combining liposomes with polypeptoid molecules. The polypeptoids serve as amphiphilic bridge materials that combine the advantages of both hydrophobic drug carriers and liposome stability maintainers. This composite approach allows high loading of hydrophobic drugs while preserving liposome structural integrity through the stabilizing effect of polypeptoid-lipid interactions.

Inventive Principle:
Principle #40Composite materials

2Reliability

If polypeptoids with hydrophobic substituents are used to interact with lipid bilayers, then the delivery of hydrophobic drugs is improved, but the complexity of the delivery system increases

Engineering Contradiction:
Improvehydrophobic drug delivery efficiencyVSAvoiddelivery system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent optimizes specific parameters of the polypeptoid molecules, including the degree of hydrophobic substitution (30-95% of repeat units), chain length, and hydrophobic group composition. By carefully controlling these parameters, the system achieves reliable hydrophobic drug delivery while maintaining relatively simple polymer structures that are easier to manufacture and regulate compared to complex multifunctional conjugates.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The hydrophobically modified polypeptoids enhance the delivery of hydrophobic drugs by interacting with liposomes, providing a stable delivery system that can encapsulate and transport these compounds efficiently.

Implementation Method 1

hydrophobically modified polypeptoids...having a polyamide backbone including a random copolymer of two or more different types of repeat units, wherein one or more of the repeat units has a nitrogen atom in the backbone having a hydrophobic substituent attached thereto

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Data Source

PatentUS12397057B2Hydrophobically modified polypeptoids and uses thereof
Publication Date: 2025.08.26 THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND
  • US12397057B2 patent drawing
  • US12397057B2 patent drawing
  • US12397057B2 patent drawing

AI summary

A variety of hydrophobically modified polypeptoids are provided. The hydrophobically modified polypeptoids can include a polyamide backbone having a random copolymer of two or more different types of repeat units, where one or more of the repeat units have nitrogen atom having a hydrophobic substituent attached thereto. Methods of making the hydrophobically modified polypeptoids are also provided, as well as uses of the hydrophobically modified polypeptoids, for example in liposomal drug delivery.